Crohn’s disease and COVID-19: points of contact
https://doi.org/10.31146/1682-8658-ecg-207-11-242-246
Abstract
The presented clinical case demonstrates the appearance of vivid clinical manifestations of Crohn’s disease after a COVID-19 infection. It was not possible to diagnose the disease in the early stages due to the lack of typical symptoms and the necessary examination. A new coronavirus infection acted as a trigger factor for the progression of Crohn’s disease. The diagnosis was confirmed during instrumental and laboratory studies, adequate therapy was prescribed, which led to a rapid relief of the attack of the disease.
About the Authors
A. A. Markova
Saratov State Medical University named after V. I. Razumovsky
Russian Federation
Russian Federation
E. I. Kashkina
Saratov State Medical University named after V. I. Razumovsky
Russian Federation
Russian Federation
A. V. Aparkina
Saratov State Medical University named after V. I. Razumovsky
Russian Federation
Russian Federation
L. V. Artyuhina
Saratov State Medical University named after V. I. Razumovsky
Russian Federation
Russian Federation
V. I. Krasnikova
Saratov State Medical University named after V. I. Razumovsky
Russian Federation
Russian Federation
References
1. Ivashkin V. T., Shelygin Yu. A., Halif I. L. et al. Clinical recommendations of the Russian Gastroenterological Association and the Association of Coloproctologists of Russia on the diagnosis and treatment of Crohn’s disease. Coloproctology. 2017; (2): 7-29. (In Russ.) doi: 10.33878/2073-7556-2017-0-2-7-29.@@ Ивашкин В. Т., Шелыгин Ю. А., Халиф И. Л. и др. Клинические рекомендации Российской Гастроэнтерологической Ассоциации и Ассоциации Колопроктологов России по диагностике и лечению болезни Крона. Колопроктология. 2017; (2): 7-29. doi: 10.33878/2073-7556-2017-0-2-7-29.
2. Grinevich V. B., Kravchuk Yu.A., Ped V. I. et al. Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology. 2020; 179 (7):4-51. (In Russ.) doi: 10.31146/1682-8658-ecg-179-7-4-51.@@ Гриневич В. Б., Кравчук Ю. А., Педь В. И. и др. Ведение пациентов с заболеваниями органов пищеварения в период пандемии COVID-19. Клинические рекомендации Научного общества гастроэнтерологов России. Экспериментальная и клиническая гастроэнтерология. 2020;179(7): 4-51. doi: 10.31146/1682-8658-ecg-179-7-4-51.
3. Hunt R. H., East J. E., Lanas A. et al. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Dig Dis. 2020; Oct 9: 1-21. doi: 10.1159/000512152.
4. Hoffmann M., Kleine-Weber H., Schroeder S. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; Apr;181(2): 271-280.e8. doi: 10.1016/j.cell.2020.02.052 Medline.
5. Siddiqi H.K., Mehra M. R. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020; May; 39(5):405-7. doi: 10.1016/j.healun.2020.03.012.
6. Xiao F., Tang M., Zheng X. et al. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020; May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055.
7. Neurath M.F. COVID-19 and immunomodulation in IBD. Gut. 2020; 69:1335-1342. doi: 10.1136/gutjnl-2020-321269.
8. Ye Q., Wang B., Zhang T. et al. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am. J. Physiol. Gastrointest. Liver. Physiol. 2020; Aug 1; 319 (2): G245-G252. doi: 10.1152/ajpgi.00148.2020.
Review
For citations:
Markova A.A., Kashkina E.I., Aparkina A.V., Artyuhina L.V., Krasnikova V.I. Crohn’s disease and COVID-19: points of contact. Experimental and Clinical Gastroenterology. 2022;(11):242-246. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-207-11-242-246
Views:
432
Email this article 